Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update
- PMID: 38822912
- DOI: 10.1007/s12033-024-01195-6
Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update
Abstract
Phage libraries are now amongst the most prominent approaches for the identification of high-affinity antibodies/peptides from billions of displayed phages in a specific library through the biopanning process. Due to its ability to discover potential therapeutic candidates that bind specifically to targets, phage display has gained considerable attention in targeted therapy. Using this approach, peptides with high-affinity and specificity can be identified for potential therapeutic or diagnostic use. Furthermore, phage libraries can be used to rapidly screen and identify novel antibodies to develop immunotherapeutics. The Food and Drug Administration (FDA) has approved several phage display-derived peptides and antibodies for the treatment of different diseases. In the current review, we provided a comprehensive insight into the role of phage display-derived peptides and antibodies in the treatment of different diseases including cancers, infectious diseases and neurological disorders. We also explored the applications of phage display in targeted drug delivery, gene therapy, and CAR T-cell.
Keywords: Antibody; CAR T-cell; Drug delivery; Gene therapy; Peptide; Phage display; Targeted therapy.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Phage display biopanning and isolation of target-unrelated peptides: in search of nonspecific binders hidden in a combinatorial library.Amino Acids. 2016 Dec;48(12):2699-2716. doi: 10.1007/s00726-016-2329-6. Epub 2016 Sep 20. Amino Acids. 2016. PMID: 27650972 Review.
-
Biased selection of propagation-related TUPs from phage display peptide libraries.Amino Acids. 2017 Aug;49(8):1293-1308. doi: 10.1007/s00726-017-2452-z. Epub 2017 Jun 29. Amino Acids. 2017. PMID: 28664268 Review.
-
In vivo Phage Display: A promising selection strategy for the improvement of antibody targeting and drug delivery properties.Front Microbiol. 2022 Sep 26;13:962124. doi: 10.3389/fmicb.2022.962124. eCollection 2022. Front Microbiol. 2022. PMID: 36225354 Free PMC article. Review.
-
The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs.Int J Pept Res Ther. 2006 Mar;12(1):79-91. doi: 10.1007/s10989-005-9002-3. Epub 2006 Mar 3. Int J Pept Res Ther. 2006. PMID: 19444323 Free PMC article.
-
Phage display derived peptides for Alzheimer's disease therapy and diagnosis.Theranostics. 2022 Jan 31;12(5):2041-2062. doi: 10.7150/thno.68636. eCollection 2022. Theranostics. 2022. PMID: 35265198 Free PMC article. Review.
Cited by
-
Engineered M13-Derived Bacteriophages Capable of Gold Nanoparticle Synthesis and Nanogold Manipulations.Int J Mol Sci. 2024 Oct 18;25(20):11222. doi: 10.3390/ijms252011222. Int J Mol Sci. 2024. PMID: 39457002 Free PMC article.
References
-
- Foglizzo, V., & Marchiò, S. (2021). Bacteriophages as therapeutic and diagnostic vehicles in cancer. Pharmaceuticals (Basel). https://doi.org/10.3390/ph14020161 - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources